Liraglutide
SCALE™ IBT
Novo Nordisk · Phase 3 · Completed · Enrollment 282
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Liraglutide | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
| Liraglutide 3.0 mg, in trial | 68 participants | 33 participants | 31 participants | n/r | 0 |
| Placebo, in trial | 25 participants | 7 participants | 23 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.